Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy - Preliminary results;Évaluation médico-économique de la chirurgie des épilepsies partielles pharmaco-résistantes de l'adulte. Étude coût-efficacité - Résultats préliminaires

Revue Neurologique

Volumn 160, Issue 5 SUPPL., 2004, Pages

  Picot, M C ^a   Neveu, D ^a   Kahane, P ^b   Crespel, A ^c   Gelisse P ^c   Hirsch, E ^d   Derambure, P ^e   Dupont, S ^f   Landre E ^g   Chassoux, F ^g   Valton, L ^h   Vignal, J P ⁱ   Marchal, C ^j   Rougier, A ^j   Lamy, C ^g   Semah, F ^g   Biraben, A ^k   Arzimanoglou, A ^l   Petit, J ^m   Thomas, P ⁿ   Dujols, P ^a   Ryvlin, P ^o   more..

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g CENTRE HOSPITALIER SAINTE ANNE   (France)

^h CHU RANGUEIL   (France)

ⁱ UNIVERSITY HOSPITAL OF NANCY   (France)

^j HÔPITAL PELLEGRIN   (France)

^k RENNES UNIVERSITY HOSPITAL   (France)

^l HÔPITAL ROBERT DEBRÉ   (France)

^m Service de Neurologie   (France)

ⁿ PASTEUR HOSPITAL   (France)

^o HÔPITAL NEUROLOGIQUE   (France)

more..

Author keywords

Cost effectiveness; Epilepsy surgery; Intractable epilepsy; Markov model

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; BRAIN SURGERY; CHILD; COGNITIVE DEFECT; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DEPRESSION; DISEASE SEVERITY; EPILEPSY; EPILEPTOGENESIS; EVALUATION; FEMALE; HOSPITALIZATION; HUMAN; INTRACTABLE EPILEPSY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; PATIENT CARE; PREOPERATIVE CARE; PROBABILITY; QUALITY OF LIFE; SENSITIVITY ANALYSIS; TISSUE DISTRIBUTION; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; DRUG RESISTANCE; ECONOMICS; FOCAL EPILEPSY; FOLLOW UP; FRANCE; HEALTH CARE COST; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; COHORT STUDIES; COMBINED MODALITY THERAPY; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DIRECT SERVICE COSTS; DRUG COSTS; DRUG RESISTANCE; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 4544287596     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (54)

1. AURAY J-P, BAIL J-N, BÉRAUD C, et al. (1998). Recommandations de bonnes pratiques des méthodes d'évaluation économique des stratégies thérapeutiques. Journal d'économie médicale, 16: 329-51.
2. BAKER GA, JACOBY A, SMITH DF, DEWEY ME, CHADWICK DW. (1994). Development of a novel scale to assess life fulfilment as part of the further refinement of a quality of life model of epilepsy. Epilepsia, 35: 591-96.
3. BEGLEY CE, FAMULARI M, ANNEGERS JF, et al. (2000). The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia, 41: 342-51.
4. BRIGGS AH, MOONEY CZ ET WONDERLING DE. (1999). Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte-Carlo simulation. Statistics in medecine, 18: 3245-3262.
5. BROWN SW ET TOMLINSON LL. (1982). The side effects and life satisfaction inventory: a self-report questionnaire for use in community surveys. British Journal of Clinical Practice, 14: 147-149.
6. BUCQUET D, CONDON S, RITCHIE K. (1990). The French version of the Nottingham Health Profile. A comparison of items weights with those of the source version. Soc Sci Med, 30: 829-835.
7. CHRISTIANSON SA, SILFVENIUS H, NILSSON M. (1995). Life satisfaction and sexuality in patients operated for epilepsy. Acta Neurol Scand, 92: 1-6.
8. COCKERELL OC, HART YM, SANDER JWAS, SHORVON SD. (1994). The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Research 18: 249-260.
9. COLLÈGE DES ÉCONOMISTES DE LA SANTÉ. (2003). Guide méthodologique pour l'évaluation économique des stratégies de santé. Paris, CES.
10. COMMISION ON NEUROSURGERY OF THE INTERNATIONAL LEAGUE AGAINST EPILEPSY. (ILAE) 1997-2001:, Wieser HG, Blume WT, et al. (2001). Proposal for a new classification of autcomes with respect to epileptic seizures following epilepsy surgery. Epilepsia, 42: 282-286.
11. CRAMER JA, PERRINE K, DEVINSKY O, COMSTOCK-BRYANT L, MEADOR K, HERMANN B. (1998). Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia, 39: 81-88.
12. DAURÈS J-P, PICOT M-C, CRESPEL A, BALDY-MOULINIER M ET EL HASNAOUI A. (1998). Evaluation of the french cross-cultural translation of the side effects and life satisfaction inventory (SEALS) in assessing cognitive and behavioral side effects of antiepileptic drugs. Epilepsia, 39.
13. DEVINSKY O, VICKREY BG, CRAMER J, et al. (1995). Development of the quality of life in epilepsy inventory. Epilepsia, 36: 1089-104.
14. DRUMMOND MF, O'BRIAN B, STODDART GL, TORRANCE GW. (1997). Methods for the economic evaluation of health care for programmes. Oxford, Oxford University Press.
15. ENGEL J. (1987). Outcome with respect to epileptic seizures. Surgical treatment of the epilepsies. Engel J. New-York, Raven Press: 553-72.
16. ENGEL JJ, SHEWMON DA. (1993). Overview: who should be considered as surgical candidate? Surgical treatment of the epilepsies. New York, Raven Press: 23-24.
17. ENGEL JJ, WIEBE S, FRENCH J, et al. (2003). Practice parameter: temporal lobe and localized neocortical resections for epilepsy, report of the quality standards subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Epilepsia, 44: 741-751.
18. FOLDVARY N, NASHOLD B, MASCHA E et al. (2000). Seizure outcomes after temporal lobectomy for temporal lobe epilepsy: a Kaplan Meier survival analysis. Neurology, 54: 630-634.
19. GULDVOG B. (1994). Patient satisfaction and epilepsy surgery. Epilepsia, 35: 597-607.
20. GULDVOG B, LOYNING Y, HAUGLIE-HANSSEN E et al. (1991). Surgical versus medical treatment of epilepsy. I. Outcome related to survival, seizures and neurologic deficit. Epilepsia, 32: 375-388.
21. GUMNIT RJ. (1992). Cost, accessibility and quality of life issues in surgery for epilepsy. Epilepsy surgery. Luders HO. New York, Raven Press: 47-50.
22. JACOBY A. (1992). Epilepsy and the quality of everyday life findings from a study of people with well-controlled epilepsy. Social science medicine, 34: 657-666.
23. JACOBY A, DEBBIE B, BAKER G, MCNAMEE P, GRAHAM-JONES S ET CHADWICK D. (1998). Uptake and costs of care for epilepsy: findings from a UK regional study. Epilepsia, 39: 776-786.
24. KELLET MW, SMITH DF, BAKER GA, CHADWICK DW. (1997). Quality of life after epilepsy surgery. Journal of Neurology, Neurosurgery and Psychiatry, 63: 52-58.
25. KING JT, SPERLING MR, JUSTICE AC ET O'CONNOR MJ. (1997). A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy. J Neurosurg, 87: 20-28.
26. KRIEDEL T. (1980). Cost-benefit of epilepsy clinics. Soc Sci Med, 14C: 35-39.
27. LANGFITT JT. (1997). Cost-effectiveness of anterotemporal lobectomie in medically intractable complex partial epilepsy. Epilepsia, 2: 154-163.
28. LUDERS HO, Comair YG. (2001). Epilepsy surgery. Philadelphia, Lippincott Williams and Wilkins.
29. MALMGREN K, HEDSTROM A, GRANQVIST R, MALMGREN H, BENMENACHEM E. (1996). Cost analysis of epilepsy surgery and of vigabatrin treatment in patients with refractory partial epilepsy. Epilepsy research, 25: 199-207.
30. MALMGREN K, SULLIVAN M, EKSTEDT G, KULLBERG G, KUMLIEN E. (1997). Health related quality of life after epilepsy surgery: a Swedish multicenter study epilepsy. Epilepsia, 38: 830-838.
31. MARKAMO ON, SALANOVA V, WHELIHAN E, EMSLEY C. (2000). Health-related quality of life outcome in medically refractory epilepsy treated with anterior temporal lobectomy. Epilepsia, 41: 749-759.
32. MCLACHLAN RS, ROSE KJ, DERRY PA, BONNAR C, BLUME WT, GIRVIN JP. (1997). Health-related quality of life and seizure control in temporal lobe epilepsy. Annales of Neurology, 41: 482-489.
33. MIHARA T, IINOUE Y, MATSUDA K, et al. (1996). Recommendations of early surgery from the viewpoint of daily quality of life. Epilepsia, 37: 33-36.
34. O'DONOGHUE MF, DUNCAN JS, SANDER JWAS (1998). The subjective handicap of epilepsy. A new approach to measuring treatment outcome. Brain, 121: 317-343.
35. PALAS J, GATES JR, DOHERTY K. (1996). A longitudinal study of social outcomes in epilepsy patients after focal resection. Epilepsia, 37: 8.
36. PICOT MC, EL HASNAOUI A, CRESPEL A, DAURÈS J-P, BALDY-MOULINIER M. (1998). Validation of the French cross-cultural translation of the quality of life in epilepsy inventory-31 (QOLIE-31) in a population based study. Epilepsia, 39.
37. PLATT M, SPERLING MR. (2002). A comparison of surgical and medical costs for refractory epilepsy. Epilepsia, 43: 25-31.
38. ROSE KJ, DERRY PA, WIEBE S, MCLACHLAN RS. (1996). Determinants of health-related quality of life after temporal lobe epilepsy surgery. Epilepsia, 5: 484-491.
39. ROUGIER A, DARTIGUES JF, COMMENGES D, CLAVERIE B, LOISEAU P, COHADON F. (1992). A longitudinal assessment of seizure outcome and overall benefit from 100 cortectomies for epilepsy. Journal of Neurology, Neurosurgery and Psychiatry, 55: 762-767.
40. SANDER JWAS. (1993). Some aspects of prognosis in the epilepsies: a review. Epilepsia, 34: 1007-1016.
41. SANDER JWAS, SILLANPÄÄ M. (1997). Natural history and prognosis. Epilepsy: a comprehensive textbook, Engel J, Jr and Pedley TA. Philadelphia, Lippincott-Raven. I: 69-86.
42. SCHILLER Y, CASCINO DG, ELSON LS, MARSH WR. (2000). Discontinuation of antiepileptic drugs after successful epilepsy surgery. Neurology, 54: 346-349.
43. SELAI CE, ELSTNER K, TRIMBLE MR. (2000). Quality of life pre and post epilepsy surgery. Epilepsy Research, 38: 67-74.
44. SIANI C, MOATTI J-P. (2003). Le traitement de l'incertitude dans les évaluations économiques des stratégies sanitaires. Rev Epidemiol Santé Publique, 51: 255-76.
45. SILLANPÄÄ M. (1995). Epidemiology of intractable epilepsy in children. Intractable epilepsy. Johannessen SI, Gram L, Sillanpää M, Tomson T. Petersfield, Wrightson Biomedical Publishing LTD: 13-23.
46. SPERLING MR, O'CONNOR MJ, SAYKIN AJ, PLUMMER C. (1996). Temporal lobectomy for refractory epilepsy. JAMA, 276: 470-475.
47. SPERLING MR, SAYKIN AJ, ROBERTS DF. (1995). Occupational outcome after temporal lobectomy for refractory epilepsy. Neurology, 45: 970-977.
48. VICKREY BG, BERG AT, SPERLING MR, et al. (2000). Relationship between seizure severity and health-related quality of life in refractory localization-related epilepsy. Epilepsia, 41: 760-764.
49. Vickrey BG, Hays RD, Engel J, et al. (1995a). Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol, 37: 158-166.
50. VICKREY BG, HAYS RD, RAUSCH R, et al. (1995b). Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery. Lancet, 346: 1445-1449.
51. VICKREY BG, HAYS RD, RAUSCH R, SUTHERLING WW, ENGEL J, BROOK RH. (1994). Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms. Epilepsia, 35: 597-607.
52. WIEBE S, BLUME WT, GIRVIN JP, ELIASZIW M, FOR THE EFFECTIVENESS AND EFFICIENCY OF SURGERY FOR TEMPORAL LOBE EPILEPSY STUDY GROUP. (2001). A randomized, controlled trial of surgery for temporal lobe epilepsy. The New England Journal of Medecine, 34: 311-318.
53. WIEBE S, GAFNI A, BLUME WT ET GIRVIN JP. (1995). An economic evaluation of temporal lobe epilepsy. Epilepsy, 8: 227-235.
54. WIEBE S, ROSE K, DERRY P, MCLACHLAN R. (1997). Outcome assessment in epilepsy: Comparative responsiveness of quality of life and psychosocial instruments. Epilepsy, 38: 430-438.